[Clinical features and treatment of osteogenic sarcoma of the jaws].
24 patients with osteogenic sarcomas of the jaws were entered in a retrospective study. 79.2% of the cases had local relapses or distant metastases, usually within the first 2 years following surgery. With primary surgical treatment the 5 year disease free survival rates in cases with maxillary manifestations ranged at 22.1% and with mandibular sarcomas at 18.2%. Thus, prognosis for osteogenic sarcomas of the jaws is to be assessed as being no more favorable than for sarcomas of the extremities. A review of the literature shows that aggressive pro- and postoperative chemotherapy must be postulated apart from radical tumor resection to improve the survival rates.
Herrmann
A
A
Klinik und Poliklinik für Mund-Kiefer-Gesichtschirurgie, Universität, Heidelberg.
Zöller
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008339:Mandibular Neoplasms / Q000401:mortality* / Q000628:therapy; D008441:Maxillary Neoplasms / Q000401:mortality* / Q000628:therapy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D012516:Osteosarcoma / Q000401:mortality* / Q000628:therapy; D012189:Retrospective Studies; D015996:Survival Rate
Zur Klinik und Therapie des osteogenen Sarkoms in Kieferbereich.